Pap smear reimbursement
This article was originally published in The Gray Sheet
Executive Summary
House bill to increase the Medicare rate for pap smear lab work from $7.15 to $14.60 - the national average production cost of the tests - is introduced June 18 by Rep. Neil Abercrombie ( D-Hawaii). The Investment in Women's Health Act of 1998 would take effect in January 1999. "We can't afford to let economic pressures prevent medical labs from continuing pap smear work," Abercrombie states in a same day release
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.